Evox Therapeutics Company
Naturally inspired. Engineered to deliver. Transformative exosome therapeutics About Us Evox’s mission is to build a platform-driven technology company to spearhead the development of exosome therapeutics for the treatment of serious, life-threatening rare diseases where there are currently limited treatment options for patients and their families. Read More Pipeline Evox is developing an internal and ... Read more
Founded Date:
2016
Total Funding:
£47.2M
Investor Type:
Company
Employee Number:
51-100
Investment Stage:
Grant
Funding Status:
Late Stage Venture
Number Of Exists:
Grant
Technology:
Data-driven Technologies
Last Funding Type:
Grant
Investors Number:
9
Industry:
PharmTech
Headquarters:
Oxford, Oxfordshire, United Kingdom
Estimated Revenue:
$10M to $50M